Format

Send to

Choose Destination
Int J Mol Sci. 2018 May 4;19(5). pii: E1360. doi: 10.3390/ijms19051360.

Acetylation Disfavors Tau Phase Separation.

Author information

1
Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, TX 77030, USA. josephine.ferreon@bcm.edu.
2
Advanced Technology Cores, Baylor College of Medicine, Houston, TX 77030, USA. antrixj@bcm.edu.
3
Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, TX 77030, USA. Kyoungjae.Choi@bcm.edu.
4
Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, TX 77030, USA. Phoebe.Tsoi@bcm.edu.
5
Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, TX 77030, USA. Kevin.MacKenzie@bcm.edu.
6
Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA. Kevin.MacKenzie@bcm.edu.
7
Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA. syjung@bcm.edu.
8
Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, TX 77030, USA. allan.ferreon@bcm.edu.

Abstract

Neuropathological aggregates of the intrinsically disordered microtubule-associated protein Tau are hallmarks of Alzheimer’s disease, with decades of research devoted to studying the protein’s aggregation properties both in vitro and in vivo. Recent demonstrations that Tau is capable of undergoing liquid-liquid phase separation (LLPS) reveal the possibility that protein-enriched phase separated compartments could serve as initiation sites for Tau aggregation, as shown for other amyloidogenic proteins, such as the Fused in Sarcoma protein (FUS) and TAR DNA-binding protein-43 (TDP-43). Although truncation, mutation, and hyperphosphorylation have been shown to enhance Tau LLPS and aggregation, the effect of hyperacetylation on Tau aggregation remains unclear. Here, we investigate how the acetylation of Tau affects its potential to undergo phase separation and aggregation. Our data show that the hyperacetylation of Tau by p300 histone acetyltransferase (HAT) disfavors LLPS, inhibits heparin-induced aggregation, and impedes access to LLPS-initiated microtubule assembly. We propose that Tau acetylation prevents the toxic effects of LLPS-dependent aggregation but, nevertheless, contributes to Tau loss-of-function pathology by inhibiting Tau LLPS-mediated microtubule assembly.

KEYWORDS:

Tau fibrillation; intrinsically disordered protein; membrane-less organelle; neurodegenerative disease; p300 HAT acetylation; post-translational modification; protein aggregation

PMID:
29734651
PMCID:
PMC5983838
DOI:
10.3390/ijms19051360
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center